 COPENHAGEN, Denmark, May 04, 2021 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq: ASND, a biopharmaceutical company that utilizes its innovative TransConTM technologies to create product candidates that address unmet medical needs, today announced that the company will participate at the BofA Securities 2021 Virtual Health Care Conference. Company executives will provide a business overview and an update on the Companys pipeline programs. 